A vaccine shown to be 100% effective against two virus strains that cause most cervical cancer could be available within a year, say manufacturers.
Gardasil worked against the sexually transmitted human papillomavirus (HPV).

Some 12,167 women aged 16 to 23 from 13 countries, including the UK, took part in the drug company study.

BBC.